The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study
Maria Fusaro,Giovanni Tripepi,Mario Plebani,Cristina Politi,Andrea Aghi,Fulvia Taddei,Enrico Schileo,Martina Zaninotto,Gaetano La Manna,Giuseppe Cianciolo,Maurizio Gallieni,Laura Cosmai,Piergiorgio Messa,Maura Ravera,Thomas L Nickolas,Serge Ferrari,Markus Ketteler,Giorgio Iervasi,Maria Cristina Mereu,Roberto Vettor,Sandro Giannini,Lorenzo Gasperoni,Stefania Sella,Maria Luisa Brandi,Luisella Cianferotti,Raffaele De Caterina
DOI: https://doi.org/10.3390/nu13103567
IF: 5.9
2021-10-12
Nutrients
Abstract:Vascular calcification and fragility fractures are associated with high morbidity and mortality, especially in end-stage renal disease. We evaluated the relationship of iliac arteries calcifications (IACs) and abdominal aortic calcifications (AACs) with the risk for vertebral fractures (VFs) in hemodialysis patients. The VIKI study was a multicenter cross-sectional study involving 387 hemodialysis patients. The biochemical data included bone health markers, such as vitamin K levels, vitamin K-dependent proteins, vitamin 25(OH)D, alkaline phosphatase, parathormone, calcium, and phosphate. VF, IACs and AACs was determined through standardized spine radiograms. VF was defined as >20% reduction of vertebral body height, and VC were quantified by measuring the length of calcium deposits along the arteries. The prevalence of IACs and AACs were 56.1% and 80.6%, respectively. After adjusting for confounding variables, the presence of IACs was associated with 73% higher odds of VF (p = 0.028), whereas we found no association (p = 0.294) for AACs. IACs were associated with VF irrespective of calcification severity. Patients with IACs had lower levels of vitamin K2 and menaquinone 7 (0.99 vs. 1.15 ng/mL; p = 0.003), and this deficiency became greater with adjustment for triglycerides (0.57 vs. 0.87 ng/mL; p < 0.001). IACs, regardless of their extent, are a clinically relevant risk factor for VFs. The association is enhanced by adjusting for vitamin K, a main player in bone and vascular health. To our knowledge these results are the first in the literature. Prospective studies are needed to confirm these findings both in chronic kidney disease and in the general population.